Figure 2
From: Early cancer diagnoses through BRCA1/2 screening of unselected adult biobank participants
Timeline of BRCA1/2 variant disclosure, medical evaluation, risk management, and diagnostic workup (cases 1–3). RRSO, risk-reducing salpingo-oophorectomy; PSA, prostate-specific antigen.
